Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Editing DNA

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Lab to Develop New Bio-Based Sustainable Materials

Climate change illustration

A venture investment fund and university bioengineering center are creating a laboratory to design more sustainable alternative materials to help address the climate crisis. . . . → Read More: Lab to Develop New Bio-Based Sustainable Materials

Infographic – U-Turn on A.I. Venture Funds in Q1

Chart: Venture funds for artificial intelligence by quarter to Q1 2023

Both the total investment dollars and number of venture deals in Q1 2023 are the lowest single quarter totals since 2019. . . . → Read More: Infographic – U-Turn on A.I. Venture Funds in Q1

Brain-Computer Device Company Gains $33M in Early Funds

Electrode microarray illustration

A company creating brain-computer interface devices to help people with disabling communications impairments is raising $33 million in its first venture round. . . . → Read More: Brain-Computer Device Company Gains $33M in Early Funds

Infographic – Climate Start-Ups Still Gaining Venture Funds

Bar chart: Annual venture funding for weather and climate start-ups through 2022

Despite a sharp downturn in venture dollars from 2021, new climate and weather forecasting companies continue to attract investments at historically high rates. . . . → Read More: Infographic – Climate Start-Ups Still Gaining Venture Funds

Infographic – Psychedelics Funding Coming Down

Bar chart: Venture funding in psychedelics, 2019-2023

Technology intelligence company CB Insights says this week that psychedelic therapies and services are generating little interest among venture investors this year, with only nine deals totaling $21 million. . . . → Read More: Infographic – Psychedelics Funding Coming Down

Biotech to Design Disease-Blocking Drugs, Gains $75M

Chemical atom model

A new company that says it can stop disease-causing proteins from forming in cells began public operations today, and is raising $75 million in its first venture round. . . . → Read More: Biotech to Design Disease-Blocking Drugs, Gains $75M

Venture Capital Group to Boost Climate Actions

Three wind energy turbines

A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals. . . . → Read More: Venture Capital Group to Boost Climate Actions

New Funds to Invest in Digital Health Start-Ups

Digital heart health graphic

A venture capital company supporting developers of digital technologies in health care says it raised $460 million to invest in early-stage digital health businesses. . . . → Read More: New Funds to Invest in Digital Health Start-Ups

Cancer Cell Therapy Biotech Launches, Raises $10M

Breast cancer cells, microscope image

A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds. . . . → Read More: Cancer Cell Therapy Biotech Launches, Raises $10M